Michael Narachi
Director/Board Member at ULTRAGENYX PHARMACEUTICAL INC.
Net worth: 947 379 $ as of 2024-04-29
Network origin in Michael Narachi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
224
| Public Company | Pharmaceuticals: Major | 224 |
| Public Company | Pharmaceuticals: Major | 50 | |
| Subsidiary | Pharmaceuticals: Major | 46 | |
| Subsidiary | Pharmaceuticals: Major | 36 | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.
18
| Non-Profit Organization | Pharmaceuticals: Major | 18 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA.
13
| Extinct | Biotechnology | 13 |
Naryx Pharma, Inc.
 Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA.
1
| Extinct | Pharmaceuticals: Major | 1 |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA.
1
| Holding Company | Medical Specialties | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Narachi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal Chief Administrative Officer Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
Amgen Ventures LLC
 Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Investment Managers | General Counsel Chief Executive Officer Director/Board Member General Counsel Private Equity Investor | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Princeton University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Chief Executive Officer | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing Chief Executive Officer | |
| Stanford University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| University of Michigan | College/University | Chief Tech/Sci/R&D Officer Undergraduate Degree Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member Investor Relations Contact | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Director/Board Member Masters Business Admin Undergraduate Degree | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| United States Naval Academy | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Virginia | College/University | Graduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member | |
Museum of Science
 Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Other Consumer Services | Director/Board Member Director/Board Member | |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
PowerVision, Inc.
 PowerVision, Inc. Electronic ComponentsElectronic Technology PowerVision, Inc. develops fluid-controlled intraocular lens. The firm provides FluidVision accommodating intraocular lens technology, which restores the vision of youth to middle aged or elderly individuals affected by presbyopia and cataracts regain to adjust focus for clear vision at all distances. The company was founded by Matthew A. Frinzi, Randy McDonald, and Barry Cheskin in 2002 and is headquartered in Belmont, CA. | Electronic Components | Director/Board Member Chief Executive Officer | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Public Communications Contact President | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree |
Statistics
International
| United States | 50 |
| Ireland | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 17 |
| Commercial Services | 6 |
| Finance | 2 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 795 |
| Corporate Officer/Principal | 272 |
| Independent Dir/Board Member | 238 |
| Chairman | 146 |
| Chief Executive Officer | 120 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Powell | 48 |
| Eckard Weber | 46 |
| Gil Omenn | 42 |
| Brian H. Dovey | 40 |
| Todd Foley | 38 |
| Joseph Lacob | 35 |
| Barbara Dalton | 35 |
| Dan Omstead | 33 |
| George Scangos | 33 |
| Carl Johan Kördel | 31 |
| Marc M. P. de Garidel | 31 |
| Robert Perez | 31 |
| Kathryn Falberg | 30 |
| Dan Turner | 29 |
| Louis C. Bock | 27 |
- Stock Market
- Insiders
- Michael Narachi
- Company connections
